Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 2349-2351, May 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ebright, R. H.
Right arrow Articles by Chen, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebright, R. H.
Right arrow Articles by Chen, L. B.

Binding of 2-Hydroxybenzo(a)pyrene to Estrogen Receptors in Rat Cytosol

Richard H. Ebright1, James R. Wong and Lan Bo Chen2

Department of Microbiology and Molecular Genetics [R. H. E.], and Dana-Farber Cancer Institute [J. R. W., L. B. C.], Harvard Medical School, Boston, Massachusetts, 02115

The potent carcinogen 2-hydroxybenzo(a)pyrene (2-OH-BP) competes for binding to the estrogen receptor in the cytosol of rat uterus and liver. The dissociation constant (Ki) for this interaction is ~=2 x 10-5 M. In contrast, 4-hydroxybenzo(a)pyrene does not bind to the estrogen receptor; 1-hydroxybenzo(a)pyrene, 5-hydroxybenzo(a)pyrene, 6-hydroxybenzo-(a)pyrene, and 12-hydroxybenzo(a)pyrene bind less tightly than does 2-OH-BP. These five chemicals are not carcinogenic. We suggest that the estrogen receptor may mediate the carcinogenic effect of 2-OH-BP or of related chemicals. One possibility is that the receptor might convey 2-OH-BP to specific sites in DNA.

1 Supported in part by NIH Grants RR-01032 and CA22659.

2 Supported in part by National Cancer Institute Grant CA22659.

Received 9/ 5/85. Revised 1/14/86. Accepted 2/ 7/86.




This article has been cited by other articles:


Home page
Toxicol SciHome page
K. C. Fertuck, J. B. Matthews, and T. R. Zacharewski
Hydroxylated Benzo[a]pyrene Metabolites Are Responsible for in Vitro Estrogen Receptor-Mediated Gene Expression Induced by Benzo[a]pyrene, but Do Not Elicit Uterotrophic Effects in Vivo
Toxicol. Sci., February 1, 2001; 59(2): 231 - 240.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. D. Charles, M. J. Bartels, T. R. Zacharewski, B. B. Gollapudi, N. L. Freshour, and E. W. Carney
Activity of Benzo[a]pyrene and Its Hydroxylated Metabolites in an Estrogen Receptor-{alpha} Reporter Gene Assay
Toxicol. Sci., June 1, 2000; 55(2): 320 - 326.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.